Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by ircm doc
Group name EquipeCTCS
Item Type Journal Article
Title Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancer
Creator Eslami-S et al.
Author Zahra Eslami-S
Author Luis Enrique Cortés-Hernández
Author Léa Sinoquet
Author Ludovic Gauthier
Author Valentin Vautrot
Author Laure Cayrefourcq
Author Laure Avoscan
Author William Jacot
Author Marie Viala
Author Quentin Dominique Thomas
Author Pierre-Jean Lamy
Author Xavier Quantin
Author Jessica Gobbo
Author Catherine Alix-Panabières
Abstract BACKGROUND: Circulating tumour cells (CTCs), circulating tumour DNA (ctDNA), and extracellular vesicles (EVs) are minimally invasive liquid biopsy biomarkers. This study investigated whether they predict prognosis, alone or in combination, in heterogenous unbiased non-small cell lung cancer (NSCLC) patients. METHODS: Plasma samples of 54 advanced NSCLC patients from a prospective clinical trial. CtDNA mutations were identified using the UltraSEEK? Lung Panel (MassARRAY® technology). PD-L1 expression was assessed in small EVs (sEVs) using an enzyme-linked immunosorbent assay. RESULTS: At least one ctDNA mutation was detected in 37% of patients. Mutations were not correlated with overall survival (OS) (HR?=?1.1, 95% CI?=?0.55; 1.83, P?=?0.980) and progression-free survival (PFS) (HR?=?1.00, 95% CI?=?0.57-1.76, P?=?0.991). High PD-L1+ sEV concentration was correlated with OS (HR?=?1.14, 95% CI?=?1.03-1.26, P?=?0.016), but not with PFS (HR?=?1.08, 95% CI?=?0.99-1.18, P?=?0.095). The interaction analysis suggested that PD-L1+ sEV correlation with PFS changed in function of CTC presence/absence (P interaction?=?0.036). The combination analysis highlighted worse prognosis for patients with CTCs and high PD-L1+ sEV concentration (HR?=?7.65, 95% CI?=?3.11-18.83, P?
Publication British Journal of Cancer
Volume 130
Issue 1
Pages 63-72
Date 2024-01
Journal Abbr Br J Cancer
Language eng
DOI 10.1038/s41416-023-02491-9
ISSN 1532-1827
Short Title Circulating tumour cells and PD-L1-positive small extracellular vesicles
Library Catalog PubMed
Extra PMID: 37973956 PMCID: PMC10781977
Tags B7-H1 Antigen, Biomarkers, Tumor, Carcinoma, Non-Small-Cell Lung, Extracellular Vesicles, Humans, Lung Neoplasms, Neoplastic Cells, Circulating, original, Prognosis, Prospective Studies
Date Added 2025/01/13 - 11:59:56
Date Modified 2025/01/16 - 09:47:10
Notes and Attachments PubMed entry (Attachment)
Texte intégral (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés